Curis Inc CRIS

NAS: CRIS | ISIN: US2312692005   15/09/2025
1,700 USD (-6,59%)
(-6,59%)   15/09/2025

2 september 2025 · Curis to Present at Upcoming Healthcare Conferences in September · Persbericht

5 augustus 2025 · Curis Provides Second Quarter 2025 Business Update · Persbericht

29 juli 2025 · Curis to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2025 · Persbericht

2 juli 2025 · Curis Announces $7.0 Million Registered Direct and Concurrent Private Placement · Persbericht

7 mei 2025 · Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

6 mei 2025 · Curis Provides First Quarter 2025 Business Update · Persbericht

29 april 2025 · Curis to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2025 · Persbericht

2 april 2025 · Curis to Present at Upcoming Healthcare Conference in April · Persbericht

31 maart 2025 · Curis Provides Fourth Quarter 2024 Business Update · Persbericht

28 maart 2025 · Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025 · Persbericht

4 september 2024 · Curis to Present at Upcoming Healthcare Conferences in September · Persbericht

1 augustus 2024 · Curis Provides Second Quarter 2024 Financial and Operating Update · Persbericht

25 juli 2024 · Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024 · Persbericht

10 juli 2024 · Curis to Present at Upcoming Healthcare Conference in July · Persbericht

8 juli 2024 · Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

14 mei 2024 · Curis Announces Additional Data from TakeAim Leukemia Study · Persbericht

10 mei 2024 · Curis to Present Updated Data from the TakeAim Leukemia Study · Persbericht

7 mei 2024 · Curis Provides First Quarter 2024 Business Update · Persbericht

30 april 2024 · Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024 · Persbericht

5 april 2024 · Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

Mijn selecties